Can Dad's Heart Health Impact Your Preeclampsia Risk?
Association of Preconception Paternal Health and Adverse Maternal Outcomes among Healthy Mothers
The vast majority of research studies working to identify risk factors and prediction models for preeclampsia are focused on the pregnant woman. But what about the other half of the "placental equation"? Researchers for this study suggest that paternal health (meaning the health of the man that contributed the sperm and half the genes to the placenta and baby) should be considered when evaluating a patient’s risk for preeclampsia, too. In this study, researchers asked if paternal health – classified by characteristics of the metabolic syndrome (large waist circumference, high triglycerides, low HDL (the “good” cholesterol), increased blood pressure, and elevated blood sugar) - are linked to maternal health during pregnancy.
Researchers analyzed pregnancy outcomes in over 650,000 healthy women in the IBM Marketscan® research database (which also included data on paternal health) and found a strong relationship between likelihood of preeclampsia and a partner with 2 or more characteristics of the metabolic syndrome. The odds of preeclampsia were 21% higher for women with partners with 2 or more of these characteristics compared to women with partners with none. That means that where 5 out of 100 average women will develop preeclampsia during pregnancy, 6 out of 100 women with partners with metabolic syndrome will. This study shows that in healthy, low risk women, prepregnancy paternal health may be worth assessing to make medical decisions about prenatal care.
LINK: https://pubmed.ncbi.nlm.nih.gov/33895399/
About Research Roundup
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
A new research study suggests that blood pressure changes during the first 20 weeks of pregnancy—called blood pressure trajectories—may give providers a peek at a woman’s risk of dev...
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...
Hypertensive disorders of pregnancy (HDP), including preeclampsia, affect 1 in 6 pregnancies. HDP is a general term for a range of mild to severe outcomes. Until now there has not been a reliabl...